N/A
Manufactured by Padagis US LLC
3,053 FDA adverse event reports analyzed
Last updated: 2026-04-15
ACTIVATED CHARCOAL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Padagis US LLC. The most commonly reported adverse reactions for ACTIVATED CHARCOAL include OVERDOSE, TOXICITY TO VARIOUS AGENTS, OFF LABEL USE, INTENTIONAL OVERDOSE, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ACTIVATED CHARCOAL.
Out of 570 classified reports for ACTIVATED CHARCOAL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 3,053 FDA FAERS reports that mention ACTIVATED CHARCOAL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include OVERDOSE, TOXICITY TO VARIOUS AGENTS, OFF LABEL USE, INTENTIONAL OVERDOSE, DRUG INEFFECTIVE, INTENTIONAL PRODUCT MISUSE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Padagis US LLC in connection with ACTIVATED CHARCOAL. Always verify the specific product and NDC with your pharmacist.